Jaya Sangodkar

2.2k total citations
24 papers, 1.3k citations indexed

About

Jaya Sangodkar is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Jaya Sangodkar has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Jaya Sangodkar's work include Ubiquitin and proteasome pathways (7 papers), Protein Tyrosine Phosphatases (6 papers) and Kruppel-like factors research (6 papers). Jaya Sangodkar is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Protein Tyrosine Phosphatases (6 papers) and Kruppel-like factors research (6 papers). Jaya Sangodkar collaborates with scholars based in United States, United Kingdom and Finland. Jaya Sangodkar's co-authors include Goutham Narla, Matthew D. Galsky, Caroline Farrington, David B. Kastrinsky, Kimberly McClinch, Sahar Mazhar, Caitlin M. O’Connor, Daniel Léonard, Sarah E. Taylor and Abbey Perl and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Jaya Sangodkar

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaya Sangodkar United States 19 1.0k 243 200 125 101 24 1.3k
Patrick L. Garcia United States 19 1.0k 1.0× 390 1.6× 319 1.6× 100 0.8× 68 0.7× 30 1.3k
Daniel T. Dransfield United States 18 780 0.8× 283 1.2× 223 1.1× 195 1.6× 91 0.9× 46 1.2k
Xiao-Feng Le United States 21 910 0.9× 462 1.9× 274 1.4× 99 0.8× 92 0.9× 23 1.3k
Gabriela Paroni Italy 20 1.1k 1.1× 277 1.1× 203 1.0× 77 0.6× 58 0.6× 34 1.3k
Eneda Toska United States 17 855 0.8× 263 1.1× 210 1.1× 77 0.6× 227 2.2× 36 1.1k
Abde M. Abukhdeir United States 17 824 0.8× 427 1.8× 258 1.3× 66 0.5× 181 1.8× 31 1.2k
Huaitian Liu United States 16 853 0.8× 280 1.2× 333 1.7× 71 0.6× 188 1.9× 31 1.2k
Xiao‐Dan Ji China 15 847 0.8× 241 1.0× 214 1.1× 220 1.8× 81 0.8× 19 1.1k
David Sekula United States 18 850 0.8× 440 1.8× 163 0.8× 77 0.6× 124 1.2× 25 1.1k
Rumey C. Ishizawar United States 8 600 0.6× 436 1.8× 111 0.6× 134 1.1× 170 1.7× 13 1.1k

Countries citing papers authored by Jaya Sangodkar

Since Specialization
Citations

This map shows the geographic impact of Jaya Sangodkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaya Sangodkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaya Sangodkar more than expected).

Fields of papers citing papers by Jaya Sangodkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaya Sangodkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaya Sangodkar. The network helps show where Jaya Sangodkar may publish in the future.

Co-authorship network of co-authors of Jaya Sangodkar

This figure shows the co-authorship network connecting the top 25 collaborators of Jaya Sangodkar. A scholar is included among the top collaborators of Jaya Sangodkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaya Sangodkar. Jaya Sangodkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bailey, Christopher M., Rena G. Lapidus, Sandrine Niyongere, et al.. (2021). PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation. Molecular Cancer Therapeutics. 20(4). 676–690. 17 indexed citations
2.
Taylor, Sarah E., Caitlin M. O’Connor, Zhizhi Wang, et al.. (2019). The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis. Cancer Research. 79(16). 4242–4257. 42 indexed citations
3.
O’Connor, Caitlin M., Daniel Léonard, Danica Wiredja, et al.. (2019). Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors. Oncogene. 39(3). 703–717. 27 indexed citations
4.
Farrington, Caroline, Rui Yuan, Sahar Mazhar, et al.. (2019). Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers. Journal of Biological Chemistry. 295(3). 757–770. 32 indexed citations
5.
Tohmé, Rita, Sudeh Izadmehr, Neil S. Dhawan, et al.. (2019). Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma. JCI Insight. 4(4). 45 indexed citations
6.
Noto, Fallon K., Kameswaran Ravichandran, Wei Zhang, et al.. (2018). Sprague Dawley Rag2 -Null Rats Created from Engineered Spermatogonial Stem Cells Are Immunodeficient and Permissive to Human Xenografts. Molecular Cancer Therapeutics. 17(11). 2481–2489. 15 indexed citations
7.
Mazhar, Sahar, Sarah E. Taylor, Jaya Sangodkar, & Goutham Narla. (2018). Targeting PP2A in cancer: Combination therapies. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(1). 51–63. 106 indexed citations
8.
Narla, Goutham, Jaya Sangodkar, & Christopher B. Ryder. (2018). The impact of phosphatases on proliferative and survival signaling in cancer. Cellular and Molecular Life Sciences. 75(15). 2695–2718. 28 indexed citations
9.
Kauko, Otto, Caitlin M. O’Connor, Evgeny Kulesskiy, et al.. (2018). PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells. Science Translational Medicine. 10(450). 99 indexed citations
10.
O’Connor, Caitlin M., Abbey Perl, Daniel Léonard, Jaya Sangodkar, & Goutham Narla. (2017). Therapeutic targeting of PP2A. The International Journal of Biochemistry & Cell Biology. 96. 182–193. 144 indexed citations
11.
Wiredja, Danica, Marzieh Ayati, Sahar Mazhar, et al.. (2017). Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. PROTEOMICS. 17(22). 18 indexed citations
12.
Kastrinsky, David B., Jaya Sangodkar, Nilesh Zaware, et al.. (2015). Reengineered tricyclic anti-cancer agents. Bioorganic & Medicinal Chemistry. 23(19). 6528–6534. 55 indexed citations
13.
Sangodkar, Jaya, et al.. (2014). 486 Development of small molecule activators of protein phosphatase 2A for the treatment of lung cancer. European Journal of Cancer. 50. 158–159. 1 indexed citations
14.
Sangodkar, Jaya, Neil S. Dhawan, Rui Yuan, et al.. (2012). Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response. Journal of Clinical Investigation. 122(7). 2637–2651. 70 indexed citations
15.
Das, Tirtha K., Jaya Sangodkar, Nicolas Nègre, Goutham Narla, & Ross Cagan. (2012). Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors. Oncogene. 32(26). 3184–3197. 54 indexed citations
16.
Sangodkar, Jaya, et al.. (2010). Lung Adenocarcinoma: Lessons in Translation from Bench to Bedside. Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine. 77(6). 597–605. 34 indexed citations
17.
DiFeo, Analisa, Fei Huang, Jaya Sangodkar, et al.. (2009). KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model. Cancer Research. 69(11). 4733–4741. 38 indexed citations
18.
Sangodkar, Jaya, Analisa DiFeo, Lauren D. Feld, et al.. (2009). Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma. Lung Cancer. 66(3). 292–297. 20 indexed citations
19.
Sangodkar, Jaya, Analisa DiFeo, Rachel Schwartz, et al.. (2008). Functional role of the KLF6 tumour suppressor gene in gastric cancer. European Journal of Cancer. 45(4). 666–676. 47 indexed citations
20.
Narla, Goutham, Analisa DiFeo, Yolanda Fernández, et al.. (2008). KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. Journal of Clinical Investigation. 118(8). 2711–2721. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick L. Garcia Breakdown of academic impact, for papers by Daniel T. Dransfield Breakdown of academic impact, for papers by Xiao-Feng Le Breakdown of academic impact, for papers by Gabriela Paroni Breakdown of academic impact, for papers by Eneda Toska Breakdown of academic impact, for papers by Abde M. Abukhdeir Breakdown of academic impact, for papers by Huaitian Liu Breakdown of academic impact, for papers by Xiao‐Dan Ji Breakdown of academic impact, for papers by David Sekula Breakdown of academic impact, for papers by Rumey C. Ishizawar
Rankless by CCL
2026